Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine Myocardial Protection in CABG
NCT02687269Phase 4Withdrawn
- Sponsor
- Policlinico Gemelli
- Start
- Apr 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ranolazine in Myocardial stunning, sponsored by Policlinico Gemelli. Planned start Apr 2019; status: withdrawn.
02
Drugs
ranolazine
03
Conditions
Myocardial stunning
Beyond the preview
Go deeper on NCT02687269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687269.